Model
Edge
Lineage Cell Therapeutics
0001878732
Filing Type
4
Filing Date
2/13/2023
Updated
2/14/23, 9:15 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership